Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances and limitations for the treatment of spinal muscular atrophy
John Day, Kelly Howell, Amy Place, et al.
BMC Pediatrics (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Oxidative stress: Roles in skeletal muscle atrophy
Han Zhang, Guangdong Qi, Kexin Wang, et al.
Biochemical Pharmacology (2023) Vol. 214, pp. 115664-115664
Closed Access | Times Cited: 98
Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment
Hisahide Nishio, Emma Tabe Eko Niba, Toshio Saito, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11939-11939
Open Access | Times Cited: 62
Frontiers in sarcopenia: Advancements in diagnostics, molecular mechanisms, and therapeutic strategies
Dequan Liu, Shijin Wang, Shuang Liu, et al.
Molecular Aspects of Medicine (2024) Vol. 97, pp. 101270-101270
Open Access | Times Cited: 19
Mesenchymal stem cell therapy for neurological disorders: The light or the dark side of the force?
Jasmina Isaković, Klara Šerer, Barbara Barišić, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 25
Spinal Muscular Atrophy: An Evolving Scenario through New Perspectives in Diagnosis and Advances in Therapies
Ilaria Angilletta, Rossella Ferrante, Roberta Giansante, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14873-14873
Open Access | Times Cited: 25
Consensus from the Brazilian Academy of Neurology for the diagnosis, genetic counseling, and use of disease-modifying therapies in 5q spinal muscular atrophy
Edmar Zanoteli, Alexandra Prufer de Queiroz Campos Araújo, Michele Michelin Becker, et al.
Arquivos de Neuro-Psiquiatria (2024) Vol. 82, Iss. 01, pp. 001-018
Open Access | Times Cited: 10
Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis
Kiterie M. E. Faller, Helena Chaytow, Thomas H. Gillingwater
Nature Reviews Neurology (2025) Vol. 21, Iss. 2, pp. 86-102
Closed Access | Times Cited: 1
Catecholaminergic dysfunction drives postural and locomotor deficits in a mouse model of spinal muscular atrophy
John G. Pagiazitis, Nicolas Delestrée, Leonie Sowoidnich, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115147-115147
Closed Access | Times Cited: 1
Alterations in cardiac function correlate with a disruption in fatty acid metabolism in a mouse model of SMA
Nandini Nair, Rachel Kline, I. E. Boyd, et al.
Human Molecular Genetics (2025)
Open Access | Times Cited: 1
Sex Difference in Spinal Muscular Atrophy Patients – are Males More Vulnerable?
Jianli Sun, Melissa A. Harrington, Ben Porter
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 5, pp. 847-867
Open Access | Times Cited: 17
Autophagy in spinal muscular atrophy: from pathogenic mechanisms to therapeutic approaches
Saman Rashid, Maria Dimitriadi
Frontiers in Cellular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 8
Diving into progress: a review on current therapeutic advancements in spinal muscular atrophy
P. S. Bagga, Sudhakar Singh, Gobind Ram, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 7
Identifying Biomarkers of Spinal Muscular Atrophy for Further Development
Jacqueline Glascock, Basil T. Darras, Thomas O. Crawford, et al.
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 5, pp. 937-954
Open Access | Times Cited: 16
Dysfunction of proprioceptive sensory synapses is a pathogenic event and therapeutic target in mice and humans with spinal muscular atrophy
CM Simon, Nicolas Delestrée, Jacqueline Montes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ study
Thomas O. Crawford, John Day, Darryl C. De Vivo, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 4
Myostatin: a potential therapeutic target for metabolic syndrome
Ming Yang, Chongbin Liu, Na Jiang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 10
Comprehensive analysis of adverse events associated with onasemnogene abeparvovec (Zolgensma) in spinal muscular atrophy patients: insights from FAERS database
Wenwen Zhang, Yizhen Yin, Dan Yang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Spinal muscular atrophy type 1 in the Caribbean: the first case report from the Dominican Republic
María Belén Martín-Sanz, Delvis Lucas-Muñoz, Manuel Colomé-Hidalgo
Frontiers in Neuroscience (2025) Vol. 18
Open Access
Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology
Rupal Dhariwal, Mukul Jain, Y. Mir, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Orthopedic Manifestations of Spinal Muscular Atrophy: Clarified and Unresolved Theoretical and Practical Issues
A.М. Zyma, Yu.M. Huk, A.V. Smaha, et al.
TERRA ORTHOPAEDICA (2025), Iss. 4(123), pp. 32-38
Closed Access
Human iPSC-Derived Motor Neuron Innervation Enhances the Differentiation of Muscle Bundles Engineered with Benchtop Fabrication Techniques
Jeffrey W. Santoso, Stephanie Karmann, Riya Verma, et al.
ACS Biomaterials Science & Engineering (2025)
Open Access
Fluoroscopic guidance for intrathecal delivery of nusinersen in pediatric patients with spinal muscular atrophy and complex spines
Shlomo Dotan, Eliyahu Perlow, Vered Shkalim Zemer, et al.
Neuromuscular Disorders (2025) Vol. 49, pp. 105336-105336
Closed Access
Families’ experiences and perspectives on the early use of powered mobility in children with spinal muscular atrophy type I in the natural context
Cristina Díaz-López, Rocío Palomo‐Carrión, Helena Romay‐Barrero, et al.
Disability and Rehabilitation Assistive Technology (2025), pp. 1-9
Open Access
What Time Is It? Circadian Rhythm Abnormalities in a Patient With Spinal Muscular Atrophy
Kelly Gardner, Kevin S. Gipson, Lawrence J. Epstein, et al.
Pediatric Pulmonology (2025) Vol. 60, Iss. 3
Closed Access
Functional and structural analysis of SITTER patients with spinal muscular atrophy
Aleksandra Bieniaszewska, Magdalena Sobieska, Ewa Gajewska
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top